Do I Need Biocompatibility Tests?

A complete guide to understanding when biocompatibility testing is required for your medical device, which ISO 10993 tests you need, and how to ensure FDA and EU MDR compliance.

Quick Assessment: Do You Need Biocompatibility Testing?

Answer these key questions to determine if biocompatibility testing applies to your device:

1

Is your device patient-contacting?

If your device or any component touches the patient (skin, tissue, blood, etc.), biocompatibility testing is likely required. Non-patient-contacting devices (e.g., external packaging, non-contact accessories) may not need testing.

2

What is the contact duration?

Limited (<24 hours): Basic tests (cytotoxicity, sensitization, irritation).
Prolonged (24h–30 days): Additional tests (systemic toxicity, chemical characterization).
Permanent (>30 days): Most comprehensive testing (genotoxicity, implantation, chronic toxicity).

3

Is it invasive or implantable?

Invasive and implantable devices require more extensive testing, including implantation testing and genotoxicity. Non-invasive devices typically need less comprehensive testing.

✓

Use Our Interactive Wizard

Get a personalized provisional biocompatibility scope based on your device profile. Our wizard helps you understand which ISO 10993 tests are commonly considered for your device.

Start Biocompatibility Wizard

Understanding Biocompatibility Testing Requirements

Biocompatibility testing evaluates how safe a medical device is when it comes into contact with the human body. The ISO 10993 series of standards provides a framework for determining which tests are required based on your device's contact type, duration, and invasiveness.

When is Biocompatibility Testing Required?

Biocompatibility testing is typically required when:

  • ✓ Your device or any component directly contacts the patient (skin, tissue, blood, etc.)
  • ✓ You are submitting a 510(k), De Novo, PMA, or EU MDR application
  • ✓ You have changed materials, suppliers, sterilization methods, or design of a previously cleared device
  • ✓ You are using new materials, coatings, adhesives, or inks in the patient-contacting path
  • ✓ Your device is invasive or implantable
⚠
Important:

Even if your device is not patient-contacting, you may still need to evaluate biocompatibility if there is any possibility of indirect contact or if regulatory authorities require it. When in doubt, consult with a biocompatibility specialist.

Which Tests Do You Need? ISO 10993 Test Matrix

The ISO 10993 standard uses a matrix approach to determine required tests based on:

Test Type ISO Standard When Required
Cytotoxicity ISO 10993-5 All patient-contacting devices (base requirement)
Sensitization ISO 10993-10 / -23 All patient-contacting devices (base requirement)
Irritation / Intracutaneous ISO 10993-10 Skin, mucosal, or compromised surface contact
Acute Systemic Toxicity ISO 10993-11 Prolonged or permanent contact (24h+)
Genotoxicity ISO 10993-3 Permanent contact, implants, or prolonged contact
Implantation ISO 10993-6 Implantable devices or tissue/bone contact
Hemocompatibility ISO 10993-4 Blood path (direct or indirect) contact
Chemical Characterization ISO 10993-18 New materials, coatings, adhesives, or process changes
Toxicological Risk Assessment ISO 10993-17 Chemical characterization identifies leachables
EtO Residuals ISO 10993-7 EtO sterilization method used
Pyrogenicity ISO 10993-11 Prolonged or permanent contact devices
Subchronic / Chronic Toxicity ISO 10993-11 Permanent contact devices (>30 days)

Contact Duration: The Key Driver

Contact duration is one of the most important factors in determining which tests you need:

Limited Contact (<24 hours)

Examples: Surgical instruments, single-use catheters, diagnostic devices

  • • Cytotoxicity (ISO 10993-5)
  • • Sensitization (ISO 10993-10 / -23)
  • • Irritation / Intracutaneous (ISO 10993-10)

Prolonged Contact (24h–30 days)

Examples: Wound dressings, temporary implants, catheters for extended use

  • • All limited contact tests
  • • Acute systemic toxicity (ISO 10993-11)
  • • Material-mediated pyrogenicity
  • • Chemical characterization (ISO 10993-18) - if new materials/process

Permanent Contact (>30 days)

Examples: Permanent implants, pacemakers, joint replacements, dental implants

  • • All prolonged contact tests
  • • Genotoxicity (ISO 10993-3)
  • • Implantation testing (ISO 10993-6)
  • • Subchronic / chronic toxicity (ISO 10993-11)
  • • Carcinogenicity (may be considered for certain implants)

Special Considerations

Blood Contact

Devices that contact blood (direct or indirect) require hemocompatibility evaluation (ISO 10993-4), including hemolysis, coagulation/platelet activation, and complement/thrombogenicity testing.

Chemical Characterization

Required when using new materials, coatings, adhesives, inks, or when changing suppliers, sterilization methods, or processes. Chemical characterization (ISO 10993-18) identifies leachables and extractables, which then require toxicological risk assessment (ISO 10993-17).

Sterilization Residuals

If using EtO sterilization, you must test for EtO residuals (ISO 10993-7). Other sterilization methods may also require residual testing depending on the materials and process.

FDA vs EU MDR Requirements

Both FDA and EU MDR require biocompatibility testing, but there are some differences:

FDA (510(k), De Novo, PMA)

  • • Follows ISO 10993 framework
  • • FDA guidance documents provide additional context
  • • May accept predicate data in some cases
  • • Chemical characterization often required for new materials

EU MDR

  • • Strictly follows ISO 10993 series
  • • Notified Body review required
  • • Chemical characterization mandatory for most devices
  • • More emphasis on risk-based approach

Ready to Find Biocompatibility Testing Labs?

Use our directory to compare accredited biocompatibility testing labs, get quotes, and find the right partner for your ISO 10993 testing needs.

Browse Biocompatibility Testing Labs
Cruxi - Regulatory Compliance Services